Via Bloomberg
- Air Canada (AC CN) raised to outperform at Macquarie, PT C$17
- Colgate (CL) raised to outperform at Exane
- Community Health (CYH) raised to neutral at Mizuho, PT $7.50
- Eaton Vance (EV) raised to neutral at BofAML
- GasLog (GLOG) raised to neutral at JPMorgan, PT $14
- Geopark (GPRK) raised to outperform at Itau BBA Securities, PT $9.80
- Golden Ocean (GOGL) raised to buy at SpareBank
- Laredo Petroleum (LPI) raised to overweight at Piper Jaffray, PT $19
- Meritor (MTOR) raised to overweight at Keybanc, PT $20
- Parkway (PKY) raised to overweight at Capital One, PT $25
- Russel Metals (RUS CN) raised to outperform at RBC, PT C$31
- Star Bulk (SBLK) raised to buy at Deutsche Bank
- Viper Energy Partners (VNOM) raised to strong buy at Raymond James
- Zhaopin (ZPIN) raised to neutral at Credit Suisse, PT $18
- Ardmore Shipping (ASC) cut to reduce at Fearnley, PT $6.70
- Bloomin’ Brands (BLMN) cut to neutral at JPMorgan, PT $20
- DHT Holdings (DHT) cut to accumulate at Fearnley, PT $5.10
- Dick’s Sporting (DKS) cut to market perform at Oppenheimer
- Enbridge Inc (ENB CN) cut to sector perform at Peters & Co, PT C$58
- Endurance International (EIGI) cut to underweight at Morgan Stanley
- Fairfax Financial Holdings (FFH CN) cut to underperform at CIBC
- Freeport (FCX) cut to sell at Deutsche Bank
- Frontline (FRO) cut to reduce at Fearnley, PT NOK56
- Gener8 (GNRT) cut to reduce at Fearnley, PT $4.70
- Lear (LEA) cut to equal-weight at Morgan Stanley, PT $149
- Lumos Networks (LMOS) cut to hold at Drexel Hamilton, PT $18
- Lumos Networks (LMOS) cut to hold at Jefferies, PT $18
- Lumos Networks (LMOS) cut to market perform at William Blair
- MakeMyTrip (MMYT) cut to reduce at Nomura, PT $29
- Moody’s (MCO) cut to equal-weight at Morgan Stanley, PT $114
- Omega Healthcare (OHI) cut to hold at Jefferies, PT $32
- Scorpio Tankers (STNG) cut to accumulate at Fearnley, PT $4.60
- Teekay Tankers (TNK) cut to sell at Fearnley, PT $2
- Volaris (VLRS) cut to equal-weight at Morgan Stanley
- Adient (ADNT) rated new overweight at Morgan Stanley, PT $95
- AnaptysBio (ANAB) rated new buy at Stifel, PT $30
- AnaptysBio (ANAB) rated new market outperform at JMP, PT $45
- AnaptysBio (ANAB) rated new outperform at Credit Suisse, PT $34
- AnaptysBio (ANAB) rated new outperform at Wedbush, PT $28
- ChemoCentryx (CCXI) rated new market outperform at JMP, PT $13
- Dynegy (DYN) reinstated neutral at Goldman, PT $10
- Ebix (EBIX) rated new buy at Sidoti, PT $80
- Freshii (FRII CN) rated new buy at Canaccord, PT C$15.50
- Freshii (FRII CN) rated new hold at Jefferies, PT C$13.50
- Freshii (FRII CN) rated new outperform at Baird, PT C$19
- Freshii (FRII CN) rated new outperform at CIBC, PT C$18
- Freshii (FRII CN) rated new outperform at Cowen, PT C$17
- Freshii (FRII CN) rated new outperform at National Bank, PT C$19
- Freshii (FRII CN) rated new outperform at RBC, PT C$17
- Horizon Global (HZN) rated new market perform at Wells Fargo
- JELD-WEN Holding (JELD) rated new buy at Deutsche Bank
- JELD-WEN Holding (JELD) rated new hold at SunTrust, PT $31
- JELD-WEN Holding (JELD) rated new market perform at FBR, PT $33
- JELD-WEN Holding (JELD) rated new neutral at JPMorgan, PT $32
- JELD-WEN Holding (JELD) rated new outperform at Baird, PT $34
- JELD-WEN Holding (JELD) rated new outperform at RBC, PT $35
- JELD-WEN Holding (JELD) rated new outperform at Wells Fargo
- JELD-WEN Holding (JELD) rated new overweight at Barclays, PT $35
- Jagged Peak Energy (JAG) rated new buy at Evercore ISI, PT $18
- Jagged Peak Energy (JAG) rated new buy at Goldman, PT $19
- Jagged Peak Energy (JAG) rated new market perform at BMO, PT $17
- Jagged Peak Energy (JAG) rated new outperform at Credit Suisse
- Jagged Peak Energy (JAG) rated new outperform at RBC, PT $20
- Jagged Peak Energy (JAG) rated new outperform at Wells Fargo
- Jagged Peak Energy (JAG) rated new overweight at JPMorgan, PT $23
- Jagged Peak Energy (JAG) rated new overweight at Keybanc, PT $18
- Jounce Therapeutics (JNCE) rated new outperform at Baird, PT $30
- Jounce Therapeutics (JNCE) rated new outperform at Cowen
- Jounce Therapeutics (JNCE) rated new outperform at Wells Fargo
- Jounce Therapeutics (JNCE) rated new overweight at JPMorgan, PT $28
- LKQ (LKQ) rated new overweight at JPMorgan, PT $41
- ObsEva (OBSV) rated new buy at Jefferies, PT $21
- ObsEva (OBSV) rated new outperform at Leerink, PT $21
- REV Group (REVG) rated new buy at Stifel, PT $33
- REV Group (REVG) rated new equal-weight at Morgan Stanley, PT $30
- REV Group (REVG) rated new hold at Deutsche Bank
- REV Group (REVG) rated new neutral at Goldman, PT $24
- REV Group (REVG) rated new outperform at Baird, PT $31
- REV Group (REVG) rated new outperform at Credit Suisse, PT $33
- REV Group (REVG) rated new outperform at Wells Fargo
- Miragen Therapeutics (MGEN) rated new outperform at Wedbush, PT $19
- ViaSat (VSAT) rated new equal-weight at Barclays, PT $75
